Smith & Nephew's
US Advanced Wound Management division today announced
that the US Food and Drug Administration has given
clearance of its newest absorbent antimicrobial barrier
dressing, ACTICOAT° Moisture Control.
The
clearance and introduction of ACTICOAT° Moisture
Control complements the company's existing ACTICOAT° range.
These are the only wound care products to feature
the patented Silcryst nanocrystalline silver technology
that provides antimicrobial barrier protection.
ACTICOAT° Moisture Control was developed over
the last two years, through collaboration between
Smith & Nephew and NUCRYST Pharmaceuticals. Smith & Nephew
launched the product at the SAWC Convention on April
22nd in San Diego, as an extension to the existing
ACTICOAT° family.
The
current ACTICOAT° range, which encompass
a three day, seven day and absorbent product have
been shown to be bactericidal against a broad range
of pathogens, including MRSA and VRE, and have lead
the way in both burn and chronic wound care. ACTICOAT
Moisture Control, with an extended wear time up to
7 days, reduces the number of dressing changes and
the resources needed to change multiple dressings,
adding to the comfort and quality of life of the
patient.
Antimicrobial barrier dressings are increasingly
used in the advanced wound care market as a barrier
to bacterial penetration, a major cause of delays
and complications to wound healing. As an effective
barrier to pathogenic bacteria, ACTICOAT Moisture
Control may help avoid serious complications associated
with nosocomial outbreaks, wound infection may be
avoided and duration of hospitalization and healthcare
related costs reduced proportionately.
The
introduction of ACTICOAT° Moisture Control
now offers the bactericidal protection synonymous
with the ACTICOAT range in a highly absorbent, easy
to use format. New ACTICOAT Moisture Control eliminates
the threats to healing and provides powerful antimicrobial
barrier protection to chronic and acute wounds.
"We are very excited to announce that we have added
ACTICOAT° Moisture Control to the Smith & Nephew
portfolio. This new product allows us to provide
even more options for our valued customers as they
treat wounds that affect their patients. We strive
to help people regain their lives and the addition
of ACTICOAT° Moisture Control will help us do
just that", said Jim Lodigiani, US Wound Management
President.
About
Smith & Nephew, Inc.
Smith & Nephew is a global medical technology
business, specializing in Advanced Wound Management,
Endoscopy, and Orthopaedics. Smith & Nephew ranks
as the global leader in arthroscopy and one of the
world's leaders in advanced wound management and
is one of the fastest growing orthopaedics companies
in the world. Smith & Nephew is dedicated to
helping improve people's lives. The company prides
itself on the strength of its relationships with
its surgeon and professional healthcare customers,
with whom its name is synonymous with the highest
standards of performance, innovation and trust. The
company has more than 8,000 employees and operates
in 33 countries around the world and generated sales
of nearly $2.3 billion.
Contact:
Rod Skaggs
Smith & Nephew, Inc.
Executive Vice President of Corporate Relations
(727)399.3457
rod.skaggs@smith-nephew.com
|
